Min.Order / FOB Price:Get Latest Price
1 Gram |
Negotiable |
lower price Vildagliptin 274901-16-5
www.wolcase.com
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1[2][3] and GIP[3] by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.[2]
Vildagliptin is a unique molecule with dual nature as it manages the glucagon levels in hypoglycemia as well as hyperglycemia.
CAS NO:571188-59-5
CAS NO:15318-45-3
CAS NO:247068-82-2
CAS NO:26239-55-4
CAS NO:7365-82-4
CAS NO:34985-41-6
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View